Cadrenal Therapeutics, Inc. - COM (CVKD)

Historical Portfolio Holders from Q1 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
350K
Holdings value Q2 2024
$165K
Value change Q2 2024
-$825K
Grand Portfolio weight change Q2 2024
0%
Number of holders
9
Number of buys Q2 2024
0
Number of sells Q2 2024
0
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 350K $165K -$825K $0.47 9
2024 Q1 1.7M $1.04M +$699K $0.61 10
2023 Q4 552K $408K -$406K $0.74 6
2023 Q3 1.11M $752K +$752K $0.68 9
2023 Q2 284 $429 -$848 $1.50 3
2023 Q1 847 $1.34K +$1.34K $1.41 3